← All stocks

TScan Therapeutics, Inc.

TCRX No buying or selling
CIK 0001783328 #4673 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

2 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lynx1 Capital Management LP entity
10% owner
8,019,148
$7.21M
+56.1%
Klencke Barbara
Director
45,000
$40.45K
+12.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Jul 2021